Octostim (Desmopressin Acetate)

Desmopressin Acetate, the active ingredient in Octostim, is a synthetic analog of vasopressin presented as an injectable solution for intravenous and subcutaneous use. It is employed to manage disorders of water balance and certain bleeding disorders in appropriate patient populations.

GNH USA supplies Octostim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Desmopressin Acetate is used in clinical practice to address conditions involving antidiuretic hormone deficiency or impaired coagulation: - Central diabetes insipidus: helps control excessive urine output and thirst. - Nocturnal enuresis: reduces nighttime bedwetting episodes in children and adolescents. - Mild hemophilia A and von Willebrand disease type 1: raises plasma factor VIII and von Willebrand factor levels to improve clotting during minor surgical procedures.

Desmopressin acetate may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Nasal congestion or rhinorrhea (when administered intranasally). - Hyponatraemia: low serum sodium, especially with high fluid intake. - Nausea or mild gastrointestinal discomfort. - Flushing or warmth sensation.

Serious or Rare Side Effects: - Seizures: typically linked to severe hyponatraemia. - Thromboembolic events: deep‑vein thrombosis or pulmonary embolism. - Severe allergic reactions: anaphylaxis or angioedema. - Hypertensive crisis: abrupt rise in blood pressure. - Cardiac arrhythmias associated with electrolyte shifts.

Desmopressin acetate requires careful monitoring and patient education to minimise risks. - Fluid restriction: limit intake to 1‑1.5 L per day when therapy is initiated to prevent hyponatraemia. - Electrolyte monitoring: check serum sodium regularly, especially in the elderly or those on diuretics. - Cardiovascular assessment: evaluate for hypertension or heart failure before starting therapy. - Concomitant drugs: avoid simultaneous use with other antidiuretic agents unless medically justified. - Pregnancy and lactation: use only if the potential benefit outweighs potential risk. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Desmopressin acetate can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Other antidiuretic agents (e.g., oxytocin, vasopressin): additive risk of hyponatraemia. - NSAIDs (e.g., ibuprofen, naproxen): may potentiate renal water retention and hyponatraemia. - Carbamazepine or other enzyme‑inducing anticonvulsants: may reduce desmopressin plasma levels.

Moderate Interactions (Monitor Closely): - Diuretics (especially thiazides): increase risk of electrolyte disturbances. - Anticoagulants (e.g., warfarin): enhanced clotting effect may require monitoring of coagulation parameters. - Selective serotonin reuptake inhibitors (SSRIs): potential for additive hyponatraemia risk. - Hormonal contraceptives: may modestly increase desmopressin exposure. - ACE inhibitors or ARBs: monitor blood pressure and renal function.